MRD / Regn No. : THBC\23-24\01840 Date : 23/06/2026
Patient Name : Geeta Kulkarni Age & Gender : 62 Yrs. / Female
Contact No. : 9820169029 UHID :
Ht / Wt / BMI : 163.5 / 63.95 / 23.92 BP S / BP D : 144 / 77
Allergies : NONE Referred By :
   
Subjective : LONG STANDING DIABETES,MILD BE NPDR,CAN START GLP1 ANALOG AFTER COMING BACK FROM US,EVEN AFTER GOOD LSM,NO F/H OF THYROID CANCER / NO PANCREATITIS / NO GALL BLADDER STONES
Objective : 26-MAY-2026 REPORTS,HB-13.4/ HBA1C-8.4%,FBS-106,TC-150/ TG-106/ LDL-68/ HDL-61,ALT-15/ AST-20,CR-0.72,T3-0.76/ T4-8.7/ TSH-3.308,VITD-88.5/ VITB12-689
Plan : TO TAKE HALF DOSE OF 0.25 MG FOR FIRST 2 DOSES - THEN CAN TAKE FULL DOSE FOR 3 DOSES,IF TOLERATES WELL - THEN INCREASE TO 0.5 MG  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TRIGLIMISAVE 2 ORAL 1-0-0 BBF
3 MTHS
2 XIGDUO 10/500 ORAL 1-0-0 ABF
3 MTHS
3 INJECTION INSULIN ASPART (100IU)
FIASP FLEXTOUCH
SQ 6-0-6 BEFORE MEALS
3 MTHS
4 THYRONORM 50 MCG ORAL 1-0-0 BBF
3 MTHS
5 ECOSPRIN AV 75+10 ORAL 0-0-1 AD
3 MTHS
6 DRISE 60,000 UNITS ORAL 1/15 DAYS ANY TIME
3 MTHS
7 OLIMAB 60 MG ORAL 1/6 MTHS ANYTIME OF DAY
TO CONTINUE
8 RESTYL 0.25MG ORAL 0-0-1 AD
2 MTHS
9 TABLET GLIMEPIRIDE (3MG) AND METFORMIN (500MG)
GLIMISAVE M3
ORAL 0-0-1 BD
2 MTHS
10 SHELCAL 500 MG ORAL 1-0-0 4 HRS AFTER THYROID MEDS
2 MTHS
11 INJ OZEMPIC 0.25 MG SC 1/WEEK ANYTIME OF DAY
4 WEEKS
12 INJ OZEMPIC 0.5 MG SC 0.5 MG / WEEK ANYTIME OF DAY
4 WEEKS
13 INJ OZEMPIC 1 MG SC 1/WEEKLY ANYTIME OF DAY
4 WEEKS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 12/Aug/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS > 45 DAYS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: